Organizations Filed Purposes:
THE CANCER RESEARCH INSTITUTE'S MISSION IS TO SAVE MORE LIVES BY FUELING THE DISCOVERY AND DEVELOPMENT OF POWERFUL IMMUNOTHERAPIES FOR ALL TYPES OF CANCER. TO ACCOMPLISH THIS, CRI FUNDS LABORATORY TRANSLATIONAL, AND CLINICAL RESEARCH EFFORTS AIMED AT LEARNING HOW TO HARNESS THE POWER OF THE IMMUNE SYSTEM TO DIAGNOSE, TREAT, AND CURE CANCER. CRI ALSO COORDINATES SCIENTIFIC, MEDICAL, AND PATIENT EDUCATION CONFERENCES ON THE SUBJECTS OF IMMUNOLOGY AND IMMUNOTHERAPY, AND DISSEMINATES INFORMATION ABOUT ADVANCES IN TUMOR IMMUNOTHERAPY TO THE MEDIA, PUBLIC, AND MEDICAL AND SCIENTIFIC COMMUNITIES.
THE CANCER RESEARCH INSTITUTE'S MISSION IS TO SAVE MORE LIVES BY FUELING THE DISCOVERY AND DEVELOPMENT OF POWERFUL IMMUNOTHERAPIES FOR ALL TYPES OF CANCER.
THE CRI ANNA-MARIA KELLEN CLINICAL ACCELERATOR PROGRAM IS AN ACTIVELY MANAGED VENTURE PHILANTHROPHY PROGRAM DESIGNED TO SPEED THE DEVELOPMENT OF CANCER IMMUNOTHERAPIES. THE STRATEGY FACILITATES RESEARCH COLLABORATION ACROSS LEADING BIOPHARMA COMPANIES AND AMONG 90 OF THE WORLD'S TOP CANCER RESEARCHERS. THE PROGRAM AIMS TO IDENTIFY AND KICK-START DEVELOPMENT OF NEXT-GENERATION COMBINATION TREATMENTS USING THE MOST PROMISING DRUGS FROM DISPARATE COMPANIES. EACH PHILANTHROPIC INVESTMENT BRINGS A NEW CANCER TREATMENT TO PATIENTS, EMPOWERS ACADEMIC RESEARCHERS TO WORK MORE CLOSELY WITH INDUSTRY, AND CREATES THE POTENTIAL FOR SIGNIFICANT FUTURE RETURNS ON INVESTMENT BACK TO CRI TO MAKE THE VENTURE FUND SELF-SUSTAINING.
THE LLOYD J. STAR PROGRAM, LAUNCHED IN 2019, PROVIDES GRANTS OF $1.25 MILLION OVER 5 YEARS TO MID-CAREER SCIENTISTS. THIS LONG-TERM FUNDING IS NOT TIED TO A SPECIFIC RESEARCH PROJECT, BUT RATHER AIMS TO PROVIDE A DEGREE OF FLEXIBILITY AND FREEDOM FOR INVESTIGATORS TO EXPLORE OUT-OF-THE-BOX AND DISRUPTIVE AVENUES OF RESEARCH. CANDIDATES SELECTED FOR THIS AWARD ARE EXPECTED TO BE FUTURE "STARS" IN THE FIELD OF CANCER IMMUNOLOGY: SCIENTISTS TAKING RISKS.
THE CRI IRVINGTON POSTDOCTORAL FELLOWSHIP PROGRAM PROVIDES SUPPORT TO FUND AND TRAIN YOUNG IMMUNOLOGISTS AND CANCER IMMUNOLOGISTS AT TOP UNIVERSITIES AND RESEARCH CENTERS AROUND THE WORLD. FELLOWS RECEIVE UP TO $175,500 OVER THREE YEARS TO COVER THE COST OF STIPEND OR SALARY, INSURANCE, AND OTHER RESEARCH-RELATED EXPENSES, SUCH AS TRAVEL TO CONFERENCES AND MEETINGS. OF THE MORE THAN 1,400 CRI POSTDOCTORAL FELLOWS FUNDED TO DATE, MANY HAVE SINCE BECOME HEADS OF MAJOR MEDICAL RESEARCH INSTITUTES, ACADEMIC LEADERS IN PRESTIGIOUS UNIVERSITIES, AND ADMIRED MENTORS TO THE NEXT GENERATION OF IMMUNOLOGISTS AND TUMOR IMMUNOLOGISTS.
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
| Name | Title | Hours Per Week | Total Salary |
|---|
| Jill O'Donnell-Tormey | CEO/DIR. OF SCIENTIFIC AFFAIRS | 45 | $469,988 |
| Alfred R Massidas | CFO/DIR. OF HUMAN RESOURCES | 40 | $303,907 |
| Lynne A Rapino | DIR.GRANT ADMIN/SPECIAL EVENTS | 40 | $257,060 |
| Vanessa Lucey | DIRECTOR OF CVF & ACCELERATOR | 40 | $246,153 |
| Sharon S Slade | DIR. OF STRATEGIC INITIATIVES | 40 | $219,505 |
| Brian M Brewer | DIR. OF MKTG & COMMUNICATIONS | 40 | $180,113 |
| Rupinder Kaur | SR. MANAGER OPS. & GIVING | 40 | $144,734 |
| Jun Tang | SR MGR CRI VENT FUND&CLIN ACC | 40 | $126,365 |
| Deanne T Marbach | DEVELOPMENT OFFICER | 40 | $124,241 |
| Qing Hua Zhang | CONTROLLER | 40 | $121,584 |
| Marla A Lawson | ASSOC DIR CORP & FDN RELATIONS | 40 | $109,408 |
| Brian J Brille | TRUSTEE | 0.25 | $0 |
| Peter Zhou | Trustee | 2 | $0 |
| Robert S Stolar | Trustee | 1 | $0 |
| Michael J Petrick | trustee | 0.5 | $0 |
| Kamini Banga | Trustee | 0.5 | $0 |
| Antonio C Alvarez Ii | Trustee | 0.5 | $0 |
| Jim Weiss | Trustee | 1 | $0 |
| Ronald G Weiner | Trustee | 1 | $0 |
| Lauren Veronis | TRUSTEE | 2 | $0 |
| Heidi Ueberroth | TRUSTEE | 0.5 | $0 |
| Diane Tuft | TRUSTEE | 1 | $0 |
| Michael B Targoff | TRUSTEE | 1 | $0 |
| James A Stern | TRUSTEE | 1 | $0 |
| Frank V Sica | TRUSTEE | 0.5 | $0 |
| Lief D Rosenblatt | TRUSTEE | 0.5 | $0 |
| Brian Riano | TRUSTEE | 0.5 | $0 |
| Alexander P Lynch | TRUSTEE | 0.5 | $0 |
| Michael M Kellen | TRUSTEE | 2 | $0 |
| Sandra Coudert Graham | TRUSTEE | 0.5 | $0 |
| Oliver R Grace Jr | TRUSTEE | 2 | $0 |
| Margot E Freedman | TRUSTEE | 0.5 | $0 |
| Sean P Fahey | TRUSTEE | 1 | $0 |
| John E Eckerson | TRUSTEE | 0.5 | $0 |
| Glenn J Desimone | TRUSTEE | 1.5 | $0 |
| W Robert Dahl | TRUSTEE | 1 | $0 |
| James M Citrin | TRUSTEE | 0.5 | $0 |
| Jennifer L Brorsen | TRUSTEE | 0.5 | $0 |
| Peter L Bloom | TRUSTEE | 1 | $0 |
| Yacov Arnopolin | TRUSTEE | 2 | $0 |
| Thomas G Mendell | SECRETARY | 1 | $0 |
| Geoffrey O Coley | TREASURER | 2 | $0 |
| Andrew M Paul | VICE CHAIRMAN | 2 | $0 |
| Jacques C Nordeman | VICE CHAIRMAN | 1 | $0 |
| Donald J Gogel | VICE CHAIRMAN | 3 | $0 |
| Edgar R Berner | VICE CHAIRMAN | 3 | $0 |
| John B Fitzgibbons | VICE CHAIRMAN | 2 | $0 |
| Andrew K Tsai | CO-CHAIRMAN | 4 | $0 |
| Paul C Shiverick | CO-CHAIRMAN | 4 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/202130209349300628_public.xml